Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · QJI

Interoperable Automated Glycemic Controller

An interoperable automated glycemic controller is a device intended to automatically calculate drug doses based on inputs such as glucose and other relevant physiological parameters, and to command the delivery of such drug doses from a connected infusion pump. Interoperable automated glycemic controllers are designed to reliably and securely communicate with digitally connected devices to allow drug delivery commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.

Product / regulatory recordCompanyPathwayDecision dateSource
Deka Research and Development Corp.510(k) clearanceOct 15, 2026FDA
CamDiab510(k) clearanceSep 16, 2026FDA
Beta Bionics, Inc.510(k) clearanceSep 11, 2026FDA
Source information

Follow the FDA links to view the original records.

All device categories